Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | ESR1 | P03372 | 2/20 | 0.58 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.54 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.50 |
| ▸ | UQCRB | P14927 | 1/20 | 0.50 |
| ▸ | ELANE | P08246 | 1/20 | 0.50 |
| ▸ | MMP3 | P08254 | 1/20 | 0.48 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.48 |
| ▸ | SENP1 | Q9P0U3 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ABL1 | P00519 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10395680 | 1.00 | GAA (0.59) | GAAPKMESR1ESR2LMNA | |
| SCHEMBL811489 | 1.00 | GAA (0.59) | GAAPKMESR1ESR2LMNA | |
| SCHEMBL811302 | 1.00 | GAA (0.59) | GAAPKMESR1ESR2LMNA | |
| SCHEMBL5311344 | 1.00 | GAA (0.59) | GAAPKMESR1ESR2LMNA | |
| SCHEMBL29724901 | 0.92 | GAA (0.67) | GAAPKMLMNACA2CA12 | |
| SCHEMBL18838 | 0.92 | GAA (0.67) | GAAPKMLMNACA2CA12 | |
| SCHEMBL3792342 | 0.92 | GAA (0.67) | GAAPKMLMNACA2CA12 | |
| SCHEMBL124022 | 0.92 | GAA (0.67) | GAAPKMLMNACA2CA12 | |
| SCHEMBL7935388 | 0.91 | HTR6 (0.61) | GAAPKMESR1ESR2LMNA | |
| SCHEMBL7929206 | 0.91 | MMP3 (0.65) | GAAPKMESR1LMNACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1924615-B1 | POLYISOBUTENE POLYOL AND MOULDING COMPOUND | BASF SE (DE) | 2010-07-28 | — | — | EP | disclosed |
| EP-1924615-A1 | POLYISOBUTENE POLYOL AND MOULDING COMPOUND | BASF SE (DE) | 2008-05-28 | — | — | EP | disclosed |
| WO-2007025699-A1 | POLYISOBUTENE POLYOL AND MOULDING COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2007-03-08 | — | — | WO | disclosed |
| EP-1437392-B9 | Control of curing of radiation-curable adhesives | WELLOMER GMBH (DE) | 2006-08-23 | — | — | EP | disclosed |
| EP-1437392-B1 | Control of curing of radiation-curable adhesives | WELLOMER GMBH (DE) | 2006-05-03 | — | — | EP | disclosed |
| US-6958382-B2 | Polyisobutenyl ethers and thioethers | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-25 | — | — | US | disclosed |
| EP-1437392-A1 | Control of curing of radiation-curable adhesives | Wellomer GmbH (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-20040102653-A1 | Polyisobutenyl ethers and thioethers | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-27 | — | — | US | disclosed |
| EP-1422246-A2 | Polyisobutenyl ethers and thioethers | BASF AG (DE) | 2004-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102653-A1 | Polyisobutenyl ethers and thioethers | PUF60, TERF2, TTPA | GAA 3524/4885PKM 536/4885ESR1 1874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.